Aprogen Biologics (003060) Revenue

― Followers

Aprogen Biologics Revenue

Aprogen Biologics had a revenue of 23.08B in the quarter ending Jun 30, 2026, with 6.75%. This bring the company's revenue in the last twelve months to 86.18B, Decreased 10.49%. In the fiscal year ending Dec 31, 2025, Aprogen Biologics had annual revenue of 73.23B with 8.68% growth.

Revenue (ttm)

86.18B

Revenue Growth

26.13%

P/S Ratio

0.33

Revenue/Employee

₩194,233,793

Employees

377

Market Cap

₩23.88B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	73.23B	5.85B	+8.68%
Dec 31, 2024	67.38B	-19.99B	-22.88%
Dec 31, 2023	87.36B	22.17B	+34.01%
Dec 31, 2022	65.19B	8.71B	+15.42%
Dec 31, 2021	56.48B	3.16B	+5.93%
Dec 31, 2020	53.32B	2.42B	+4.75%
Dec 31, 2019	50.90B	5.51B	+12.13%
Dec 31, 2018	45.40B	-705.56M	-1.53%
Dec 31, 2017	46.10B	―	―